Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.89
+0.18 (1.54%)
At close: Aug 21, 2026, 4:00 PM EDT
11.88
-0.01 (-0.08%)
After-hours: Aug 21, 2026, 5:13 PM EDT

Kura Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
70.24149.1224.4637.3251.890.67
Short-Term Investments
448.78518.14502.93386.64386.18427.29
Cash & Short-Term Investments
519.03667.24727.4423.96437.99517.96
Cash Growth
-17.71%-8.27%71.57%-3.20%-15.44%-18.21%
Accounts Receivable
9.458.82.06---
Other Receivables
3.63.83.31.10.91.4
Receivables
13.0512.65.361.10.91.4
Inventory
2.490.41----
Prepaid Expenses
24.8828.4112.077.427.542.93
Total Current Assets
559.44708.66744.83432.48446.43522.29
Property, Plant & Equipment
14.6215.167.498.856.388.25
Other Long-Term Assets
13.7314.547.857.63.53.52
Total Assets
587.79738.36760.16448.94456.31534.05

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.395.021.472.31.533.24
Accrued Expenses
52.5861.0846.4231.4620.2116.96
Current Portion of Long-Term Debt
4.22-2.61---
Current Portion of Leases
1.291.281.881.512.322.26
Current Income Taxes Payable
0.060.242.06---
Current Unearned Revenue
55.4848.9824.27---
Other Current Liabilities
2.170.38----
Total Current Liabilities
118.19116.9778.7135.2624.0622.46
Long-Term Debt
5.579.716.929.339.16-
Long-Term Leases
13.379.475.196.362.554.61
Long-Term Unearned Revenue
398.6424.91253.91---
Other Long-Term Liabilities
3.623.171.80.710.270.38
Total Liabilities
539.36564.23346.5251.6636.0327.44

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,3651,3471,3081,120997.11941.36
Retained Earnings
-1,316-1,174-895.42-721.44-568.81-432.97
Comprehensive Income & Other
-1.211.020.76-1.27-8.03-1.79
Shareholders' Equity
48.43174.14413.64397.27420.28506.61
Total Liabilities & Equity
587.79738.36760.16448.94456.31534.05

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
24.4620.4616.5917.214.026.88
Net Cash (Debt)
494.57646.78710.8406.76423.96511.09
Net Cash Growth
-19.09%-9.01%74.75%-4.06%-17.05%-17.35%
Net Cash Per Share
5.607.388.255.556.337.70
Filing Date Shares Outstanding
88.9688.3380.7576.1468.4466.61
Total Common Shares Outstanding
88.9587.8678.2374.3568.3166.57
Working Capital
441.25591.69666.12397.22422.37499.83
Book Value Per Share
0.541.985.295.346.157.61
Tangible Book Value
48.43174.14413.64397.27420.28506.61
Tangible Book Value Per Share
0.541.985.295.346.157.61
Machinery
3.93.843.212.772.61.99
Leasehold Improvements
7.296.921.741.541.541.53
SEC Filings: 10-K · 10-Q